PHP
EIGR

Parkman Healthcare Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Parkman Healthcare Partners’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,758
Closed -$332K – 98
2022
Q2 		$332K Buy
1,758
+91
+5% +$17.2K 0.12% 74
2022
Q1 		$415K Buy
+1,667
New +$415K 0.12% 76